Cite
HARVARD Citation
Macaluso, F. et al. (2021). SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501. Journal of gastroenterology and hepatology. 36 (11), pp. 3041-3049. [Online].